The Asia pacific mammography market size size was USD 431.69 Million in 2022 and is likely to reach USD 1.00 Billion by 2031, expanding at a CAGR of 9.87% during 2023–2031. The growth of the market is attributed to rising incidence of breast cancer in the Asia pacific region.
The mammography is a standard diagnostic and screening technique used to screen presence of breast cancer. The mammography process includes low energy X-rays for the early detection of breast cancer.
SmartCurve is 3D mammogram which is more accurate and comfortable. SmartCurve breast shape paddle make mammogram more comfortable. Breast cancer is one of the major common cancers among women due to ethnicity is reported by the center for disease control (CDC).
The COVID-19 pandemic affected the demand and supply of the Asia pacific mammography market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
-
The research and development in breast cancer therapies and advances in breast imaging modalities is estimated to drive the Asia pacific mammography market.
-
In the Asian countries breast cancer is the major common cancer than the western countries due to the lifestyle and dietary changes is projected to drive the Asia pacific mammography market.
-
Growing healthcare infrastructure in the region and rising prevalence of breast cancer is estimated to boost the market during the forecast period.
-
The expensive procedures are hampering the Asia pacific mammography market growth during the forecast period.
-
Stringent regulatory laws and side effects of mammography are hindering the market growth during the forecast period.
-
Increasing cancer population and development in the medical sector is fueling the mammography market during the forecast period.
Scope of Mammography Market Report
The report on the Asia pacific mammography market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Mammography Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Products (Digital Systems, Analog Systems, Breast Tomosynthesis, and Others), End Users (Hospitals, Diagnostic Centers, and Others)
|
Regional Scope
|
Asia Pacific
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
GE Healthcare; Fujifilm Holdings Corporation; Koninklijke Philips N.V.; Hologic Inc.; Siemens Healthineers AG
|
Asia Pacific Mammography Market Segment Insights
The digital system segment is expected to grow at a rapid pace
Based on products, the Asia pacific mammography market is divided into digital systems, analog systems, breast tomosynthesis, and others. The digital systems segment is expected to grow at a rapid pace during the forecast period because the digital system is advance and specialized form of mammography that uses computers and digital receptors instead of X-ray film to examine breast tissue for tumor presence.
The advance development in the digital mammography system and increasing number of countries shifted towards this new technology, due to their properties such as wide dynamic change, low contrast objects, and improved diagnostic quality of images, especially when examining denser breasts.
They come with an added advantages of soft copy image displays and soft copy reding, which can easily transfer. The digital mammography system offers great quality, high precision, and high efficiency results is expected to drive the Asia pacific mammography market during the forecast period.
The diagnostic centers segment is projected to expand at a considerable CAGR
On the basis of end users, the Asia pacific mammography market is segmented into hospitals, diagnostic centers, and others. The diagnostic centers segment is projected to expand at a considerable CAGR during the forecast period due to increasing demand of mammography instrument in the diagnostic centers. However, the hospitals segment is anticipated to hold a key share of the market during forecast period due to increasing multispecialty hospital in the region.
Japan is anticipated to constitute a key market share
In terms of geography, the Asia pacific mammography divided into China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific. Japan is anticipated to constitute a key market share during the forecast period because the prevalence of breast cancer is significantly increasing in past few years is estimated to drive the mammography market during the forecast period.
Segments
The Asia pacific mammography market has been segmented on the basis of
Products
- Digital Systems
- Analog Systems
- Breast Tomosynthesis
- Others
End Users
- Hospitals
- Diagnostic Centers
- Others
Geography
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Key Players
Competitive Landscape
Key players competing in the Asia pacific mammography market include GE Healthcare; Fujifilm Holdings Corporation; Koninklijke Philips N.V.; Hologic Inc.; Siemens Healthineers AG
These key players are constantly implementing several marketing strategies such as merger & acquisitions, capital investments, partnerships, and new product development to sustain industry position in the market.